Global Radiopharmaceuticals Market to Register Substantial Expansion by 2026||General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A., Nordion (Canada) Inc

An international Radiopharmaceuticals market report explains better market perspective in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behaviours. The report also endows with the information, statistics, facts and figures which are very helpful for the companies to maximize or minimize the production of goods depending on the states of demand. Also, the report brings into focus, the more important aspects of the market or Pharmaceutical industry. The data involved in the credible Radiopharmaceuticals market document can be very necessary when it comes to dominating the market or making a mark in the market as a new emergent.

The global radiopharmaceuticals market is expected to rise to an estimated value of USD 11.85 billion by 2026 registering a substantial CAGR of 9.30% in the forecast period of 2019-2026. In the rise in market can be attributed to increasing prevalence of cancer and cardiovascular chronic diseases, rising health expenditure and technological advancements.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @

Few of the major market competitors currently working in the radiopharmaceuticals market are Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A., Nordion (Canada) Inc., Advanced Accelerator Applications, Surgery Theater, Positron Corporation, NTP, IsoPET, Eli Lilly and Company., Jubilant Pharma. LLC, Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Areva Pharma, Merck & Co., Inc., Navidea Biopharmaceuticals, Inc., Eckert & Ziegler., Siemens Healthcare Private Limited, Novartis AG, Curium, among others.

Market Drivers

  • Increasing prevalence of cancer and cardiovascular chronic diseases, which is creating need for early diagnosis and treatment
  • Rising healthcare expenditure boosts the growth of this market
  • Growing awareness about the benefits of radiopharmaceuticals amongst healthcare providers also expands the growth of this market
  • Technological advancements an developments which allows the  use of radio-labeled peptides and monoclonal antibodies for the diagnosis and treatment of cancerous tumors
  • Increasing preference of SPECT and PET scans and growing preference of disease targeted cancer therapy

Market Restraints

  • Stringent regulatory guidelines and high cost of devices using radioisotopes
  • Short half-life of radiopharmaceutical

Table of Contents:

1 Introduction

2 Research Methodologies

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Compliance in Radiopharmaceuticals Market

8 Radiopharmaceuticals Market, By Service

9 Radiopharmaceuticals Market, By Deployment Type

10 Radiopharmaceuticals Market, By Organization Size

11 Radiopharmaceuticals Market Analyses, By Vertical

12 Geographic Analyses

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

13 Competitive Landscapes

14 Detailed Company Profiles

15 Related Reports

Request for Detailed TOC:

Segmentation: Global Radiopharmaceuticals Market

By Type

  • Diagnostic Nuclear Medicine
    • Spect Radiopharmaceuticals
      • Tc-99m
      • Tl-201
      • Ga-67
      • I-123
      • Other Spect Isotopes
    • Pet Radiopharmaceuticals
      • F-18
      • Ru-82
      • Other Pet Isotopes
  • Therapeutic Nuclear Medicine
    • Alpha Emitters
      • Ra-223
    • Beta Emitters
      • I-131
      • Y-90
      • Sm-153
      • Re-186
      • Lu-177
      • Other Beta Emitters
    • Brachytherapy Isotopes
      • I-125
      • Ir-192
      • Pd-103
      • Cs-131
      • Other Brachytherapy Isotopes

By Application

  • Diagnostic Applications
    • Spect Applications
      • Cardiology
      • Lymphoma
      • Neurology
      • Thyroid
      • Other Spect Applications
    • Pet Applications
      • Oncology
      • Cardiology
      • Neurology
      • Other Pet Applications
  • Therapeutic Applications
    • Thyroid
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumors
    • Other Therapeutic Applications

By Procedural Volume

  • Diagnostic Procedures
    • Spect Radiopharmaceuticals
    • Pet Radiopharmaceuticals
  • Therapeutic Procedures
    • Beta Emitters
    • Alpha Emitters
    • Brachytherapy Isotopes

By Source

  • Nuclear Reactors
  • Cyclotrons

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Cancer Research Institutes
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Enquire Here Get customization & check discount for report @:

Study Highlights

  1. To analyze the market size of the market and infer the key trends from it.
  2. Industry Chain Suppliers of Radiopharmaceuticals market with Contact Information
  3. The key findings and recommendations highlight crucial progressive industry trends in the Radiopharmaceuticals Market, thereby allowing players to develop effective long term strategies
  4. To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the Radiopharmaceuticals market
  5. Extensive analysis of the key segments of the industry helps in understanding the trends in types of Radiopharmaceuticals across Global.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Back to top button